Business intelligence for bio/pharma drugs - DrugPatentWatch

GET INSIGHTS INTO THE BIGGEST REVENUE-CHANGING EVENTSBy tracking patent expirations, patent litigation, generic and biosimilar development, you can anticipate these market-shaping forces and stay one step ahead. Branded drug companies can experience precipitous revenue erosion as generic drugs rapidly gain market share. All the while patients, physicians, payers, pharmacists, and other healthcare stakeholders must race to keep up.

This course answers the following questions to help you adapt:When will key drug patents expire. How can I write stronger patents. How can I defeat drug patents.

How can I find, evaluate, and plan for generic market entry opportunities. How can I find proprietary out-of-court settlements and deal terms. Comprehensive and actionable coverage of commercial, legal, and regulatory factors builds a solid foundation for strategic thinking.

Diverse case studies build on this groundwork by analyzing and explaining real-work examples to form the underpinning for your tactical plans. *INCLUDES FREE COMPANION TEXTBOOKThis course is the product of more than twenty years of providing guidance to drug development companies and other healthcare stakeholders. Through developing the first website on the business of biotechnology in the 1990s (now owned by the New York Times), editing and publishing the Journal of Commercial Biotechnology, and leading data analytics for a subsidiary of Scientific American, I have had the fortune of spending considerable time at the bleeding edge of the commercial side of drug development.